|
Interagency Serological Working Group
|
Committee, Work group, Advisory group, or Task Force
|
BARDA, CDC, FDA
|
NIAID
|
Coordinating influenza serological studies and capabilities across agencies.
|
|
Interagency Task Force on Military and Veterans Mental Health (ITF)
|
Committee, Work group, Advisory group, or Task Force
|
ACL, OS, SAMHSA
|
NIMH
|
Executive Order 13625, Improving Access to Mental Health Services for Veterans, Service Members, and Military Families, was released on August 31, 2012, and directed the Departments of Defense (DoD), Veterans Affairs (VA), and Health and Human Services (HHS) to ensure that Veterans, Service Members, and their families have access to needed mental health services and support. The Executive Order also established the Interagency Task Force on Military and Veterans Mental Health (ITF) and directed it to provide an annual review of agency actions, to define specific goals and metrics to aid in measuring progress, and make additional recommendations as appropriate to the President to improve mental health and substance use disorder treatment services for Veterans, Service Members, and their families. The ITF, co-chaired by the DoD Assistant Secretary for Health Affairs, the VA Under Secretary for Health, and the HHS Administrator for the Substance Abuse and Mental Health Services Administration, tracks and reports progress in executing all activities resulting from recommendations made pursuant to the Executive Order.
|
|
Interagency Task Force on the Arts and Human Development
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, SAMHSA
|
NICHD, NCCIH, NCI, NIA, NIMH, OD/DPCPSI/OBSSR
|
Beginning in 2011, the National Endowment for the Arts (NEA) has convened a Federal Interagency Task Force on the Arts and Human Development to encourage more and better research on how the arts can help people reach their full potential at all stages of life.
|
|
Interagency Task Force on Trauma-Informed Care
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CMS, CDC, IHS, FDA, HRSA, OMHA, ACF, ASPE, OCR, SAMHSA
|
NICHD
|
CMHS leads the Interagency Task to develop best practices for trauma-informed identification, referral, and support. The Interagency Task Force on Trauma-Informed Care (TIC Task Force) was established on October 13th, 2018 of the Public Law 115-271, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act of 2018 under Subtitle N, Section 7132. Duties include: To identify, evaluate, and make recommendations regarding: (1) best practices with respect to children and youth, and their families as appropriate, who have experienced or are at risk of experiencing trauma; and (2) ways in which Federal agencies can better coordinate to improve the Federal response to families impacted by substance use disorders and other forms of trauma
|
|
Interagency Workgroup on Coordinating Opportunities for Evaluating Dolutegravir and Neural Tube Defects Association
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NICHD, NIAID
|
This is a group addressing the potential association of dolutegravir and neural tube defects and associated research and policy issues.
|
|
Interagency Workgroup on Technology to Facilitate Aging in Place
|
Research Initiative
|
ACL, CMS, FDA
|
NIA, NCI, NHLBI, NIBIB, NINDS, NINR
|
The purpose of this Trans-National Institutes of Health (NIH) Inter-Agency group is to develop new platforms for everyday life technology that will enhance the common goals of multiple NIH institutes and other federal government agencies by improving the capability to rapidly conduct peer-reviewed technology research to facilitate aging in place, with a special emphasis on people from underrepresented groups. A platform is a group of technologies that are used as a base upon which other applications, processes or technologies are developed.
|
|
Interagency Working Group in the Glycosciences
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIGMS, NCI, NICHD, NIDCR, NIDDK
|
This group meets annually to identify synergies, discuss progress on the development of national standards for carbohydrates, and exchange information on the glycosciences being pursued at each agency
|
|
Interagency working group on Biological Data Sharing
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIGMS, NCI
|
The working group will identify the diverse types of biological and clinical data, define specific needs and best practices for storing, managing, curating, archiving, and maintaining the confidentiality and integrity of these data, and define agency roles and responsibilities for addressing research and policy (exclusive of regulatory) priority gaps to enable data sharing. The working group will develop a road map to enable robust sharing and maximize reuse of data, identifying opportunities for interagency coordination, and academic, industrial, and international partnerships.
|
|
Interagency Working Group on Harmful Algal Bloom and Hypoxia Research and Control Act (IWG-HABHRCA)
|
Committee, Work group, Advisory group, or Task Force
|
FDA, CDC
|
NIEHS
|
Harmful algal bloom (HAB) and hypoxia (severe oxygen depletion) events are scientifically complex and economically damaging. They challenge our ability to safeguard the health of our nation’s coastal, Great Lakes, and freshwater ecosystems. Nearly every state experiences some type of hypoxia or HAB event. Federal agencies are working together to advance the understanding of HAB and hypoxia events, and respond to, detect, predict, control, and mitigate these events to the greatest extent possible, as mandated by the Harmful Algal Bloom and Hypoxia Research and Control Amendments Act of 2014 (HABHRCA).
|
|
Interagency Working Group on Open Science
|
Committee, Work group, Advisory group, or Task Force
|
ACL, AHRQ, CDC, FDA, OS
|
OD/OSP, NLM, OD/OER
|
Advance Federal efforts to support open science by increasing access to and use of the results of Federally funded research and development.
|